NHIA Community
NHIA logo
Join NHIA Today
Member Portal
NHIA Community
Donate

News Category: Press Releases

NHIA Releases Commercial Payor Recommendations to Improve Access, Create Efficiencies, and Reduce the Total Cost of Care

  • January 31, 2023
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to reduce administrative burden and remove barriers to accessing certain infusion services.

Patient, Stakeholder Groups Urge Congress to Address Medicare’s Failed Home Infusion Benefit

  • October 31, 2022
A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) and increase access to home infusion therapy for Medicare beneficiaries.

Registration Open for NHIA’s 2023 Annual Conference in Washington, D.C.

  • October 25, 2022
Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C. 

Patient-Reported Outcomes for Understanding of Instructions and Success Rates in the 65+ Age Group Receiving Home-Based Outpatient Parenteral Antimicrobial Therapy (OPAT)

August 4, 2022

Full text | Download pdf

Danell Haines, PhD, Research Consultant; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA

Patients in the 65+ age group and those receiving outpatient parenteral antimicrobial therapy (OPAT) in the home setting are increasing. There is a void in research that investigates OPAT satisfaction and outcomes in the 65+ age group. To better serve the home infusion needs of this population, an investigation of the patient’s OPAT success rate and understanding of home infusion instructions is needed. The purpose of this study is to determine if differences exist between OPAT patients aged 18-64 and 65+ in their understanding of home infusion instructions and their therapy success rate.

Read More »

NHIA’s Michelle Simpson Earns Medical Writer Certification

July 8, 2022

The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).

Read More »

Considerations for Addressing ExactaMix Automated Compounding Device (ACD) Valve Set Supply Disruption

April 29, 2022

On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.

Read More »

NHIA Releases Comments on California Senate Bill 958

April 26, 2022

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »

National Home Infusion Foundation Launches Infusion Journal

April 11, 2022

The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

Read More »

NHIA Submits Comments on DIR Proposed Rule

March 22, 2022

NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).

Read More »

A Multi-Center Time Study of Home Infusion Pharmacist Professional Services

March 9, 2022

Abstract | Download pdf

Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA

Pharmacist professional services are paramount to the success of the home infusion process. Using home infusion pharmacist time utilization data collected in this study, the amount of time the home infusion pharmacist spends managing and caring for the patient was determined. The categories of professional services the pharmacist provides and the time and task differences between therapy types and methods of administration was also determined.

Read More »

A Multi-Center Study of Home Infusion Services in Rural Areas

March 9, 2022

Full text | Download pdf

Steven Ward, WellSky; Bill Noyes, NHIA; Connie Sullivan, BSPharm, NHIA; Danell Haines, PhD, Research Consultant

Approximately 15% of the U.S. population lives in rural areas. It is recognized that rural Americans have fewer health care opportunities when compared to metropolitan residents. This study aimed to determine the annual percentage of home infusion patients living and receiving home infusion services in rural areas.

Read More »

A 10-Year Retrospective Pilot Study of Parenteral Diphenhydramine Use in Home Infusion Patients

March 8, 2022

Full text | Download pdf

Mary Beth Letourneau, PharmD, New England Life Care; Erica Sievert, PharmD, New England Life Care; Amy MacInnis, PharmD, New England Life Care

Patients who administer chronic parenteral diphenhydramine are at risk of developing behavioral issues that may represent misuse or abuse. The purpose of this study was to assess potential risk factors and comorbidities for medication noncompliance in the home infusion patient population prescribed parenteral diphenhydramine.

Read More »

Patient-Reported Outcomes for Understanding of Instructions and Success Rates in the 65+ Age Group Receiving Home-Based Outpatient Parenteral Antimicrobial Therapy (OPAT)

August 4, 2022

Full text | Download pdf

Danell Haines, PhD, Research Consultant; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA

Patients in the 65+ age group and those receiving outpatient parenteral antimicrobial therapy (OPAT) in the home setting are increasing. There is a void in research that investigates OPAT satisfaction and outcomes in the 65+ age group. To better serve the home infusion needs of this population, an investigation of the patient’s OPAT success rate and understanding of home infusion instructions is needed. The purpose of this study is to determine if differences exist between OPAT patients aged 18-64 and 65+ in their understanding of home infusion instructions and their therapy success rate.

Read More »

NHIA’s Michelle Simpson Earns Medical Writer Certification

July 8, 2022

The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).

Read More »

Considerations for Addressing ExactaMix Automated Compounding Device (ACD) Valve Set Supply Disruption

April 29, 2022

On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.

Read More »

NHIA Releases Comments on California Senate Bill 958

April 26, 2022

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »

National Home Infusion Foundation Launches Infusion Journal

April 11, 2022

The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

Read More »

NHIA Submits Comments on DIR Proposed Rule

March 22, 2022

NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).

Read More »

A Multi-Center Time Study of Home Infusion Pharmacist Professional Services

March 9, 2022

Abstract | Download pdf

Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA

Pharmacist professional services are paramount to the success of the home infusion process. Using home infusion pharmacist time utilization data collected in this study, the amount of time the home infusion pharmacist spends managing and caring for the patient was determined. The categories of professional services the pharmacist provides and the time and task differences between therapy types and methods of administration was also determined.

Read More »

A Multi-Center Study of Home Infusion Services in Rural Areas

March 9, 2022

Full text | Download pdf

Steven Ward, WellSky; Bill Noyes, NHIA; Connie Sullivan, BSPharm, NHIA; Danell Haines, PhD, Research Consultant

Approximately 15% of the U.S. population lives in rural areas. It is recognized that rural Americans have fewer health care opportunities when compared to metropolitan residents. This study aimed to determine the annual percentage of home infusion patients living and receiving home infusion services in rural areas.

Read More »

A 10-Year Retrospective Pilot Study of Parenteral Diphenhydramine Use in Home Infusion Patients

March 8, 2022

Full text | Download pdf

Mary Beth Letourneau, PharmD, New England Life Care; Erica Sievert, PharmD, New England Life Care; Amy MacInnis, PharmD, New England Life Care

Patients who administer chronic parenteral diphenhydramine are at risk of developing behavioral issues that may represent misuse or abuse. The purpose of this study was to assess potential risk factors and comorbidities for medication noncompliance in the home infusion patient population prescribed parenteral diphenhydramine.

Read More »
News Archive

QUick links

NHIA Member Links

About Us

Get in touch

© 2024, National Home Infusion Association
All Rights Reserved by NHIA | Privacy Policy